Grade |
| TOXICITY |
0 |
1 |
2 |
3 |
4 |
|
Haematology |
WBC (x103/ l) |
4.0 |
3.0 - 3.9 |
2.0 - 2.9 |
1.0 - 1.9 |
< 1.0 |
|
Platelets (x103/ l) |
WNL |
75.0 - normal |
50.0 - 74.9 |
25.0 - 49.9 |
< 25.0 |
|
Haemoglobin (g/dl) |
WNL |
10.0 - normal |
8.0 - 9.9 |
6.5 - 7.9 |
< 6.5 |
|
Granulocytes/ Bands (x103/ l) |
2.0 |
1.5 - 1.9 |
1.0 - 1.4 |
0.5 - 0.9 |
< 0.5 |
|
Lymphocytes (x103/ l) |
2.0 |
1.5 - 1.9 |
1.0 - 1.4 |
0.5 - 0.9 |
< 0.5 |
|
| Haemorrhage |
none |
mild, no |
gross, 1 - 2 units transfusion per
episode |
gross, 3 - 4 units transfusion per
episode |
massive, > 4 units transfusion
per episode |
|
Coagulation |
| Fibrinogen |
WNL |
0.99 - 0.75 x N |
0.74 - 0.50 x N |
0.49 - 0.25 x N |
< 0.25 x N |
|
Prothrombin time (Quick) |
WNL |
1.01 - 1.25 x N |
1.26 - 1.50 x N |
1.51 - 2.00 x N |
> 2.00 x N |
|
Partial thrombo- plastin time |
WNL |
1.01 - 1.66 x N |
1.67 - 2.33 x N |
2.34 - 3.00 x N |
> 3.00 x N |
|
Metabolic |
Hyperglycaemia (mg/dl) |
< 116 |
116 - 160 |
161 - 250 |
251 - 500 |
> 500 or ketoacidosis |
|
Hypoglycaemia (mg/dl) |
> 64 |
55 - 64 |
40 - 54 |
30 - 39 |
< 30 |
|
| Amylase |
WNL |
< 1.5 x N |
1.5 - 2.0 x N |
2.1 - 5.0 N |
> 5.0 x N |
|
Hypercalcaemia (mg/dl) |
< 10.6 |
10.6 - 11.5 |
11.6 - 12.5 |
12.6 - 13.4 |
13.5 |
|
Hypocalcaemia (mg/dl) |
> 8.4 |
8.4 - 7.8 |
7.7 - 7.0 |
6.9 - 6.1 |
6.0 |
|
Hypomagnesaemia (mg/dl) |
> 1.4 |
1.4 - 1.2 |
1.1 - 0.9 |
0.8 - 0.6 |
0.5 |
|
Gastrointestinal |
| Nausea |
none |
able to eat reasonable intake |
intake significantly decreased but can
eat |
no significant intake |
__ |
|
| Vomiting |
none |
1 episode in 24 hrs |
2 - 5 episodes in 24 hrs |
6 - 10 episodes in 24 hrs |
> 10 episodes in 24 hrs or
requiring paren- teral support |
|
| Diarrhoea |
none |
increase of 2 - 3 stools / day over
pre-Rx |
increase of 4 - 6 stools / day, or
nocturnal stools, or moderate cramping |
increase of 7 - 9 stools / day, or
incontinence, or severe cramping |
increase of > 10 stools / day or
grossly bloody diarrhoea, or
need for paren- teral support |
|
| Stomatitis |
none |
painless ulcers, erythema, or
mild soreness |
painful erythema, oedema, or ulcers
but can eat solids |
painful erythema, oedema, or ulcers
and cannot eat solids |
requires paren- teral or enteral
support for alimentation |
|
Liver |
| Bilirubin (N = 17 µmol/L) |
WNL |
----- |
< 1.5 x N |
1.5 - 3.0 x N |
> 3.0 x N |
|
Transaminase (SGOT, SGPT) |
WNL |
2.5 x N |
2.6 - 5.0 x N |
5.1 - 20.0 x N |
> 20.0 x N |
|
Alk Phos or 5 nucleotidase |
WNL |
< 2.5 x N |
2.6 - 5.0 x N |
5.1 - 20.0 x N |
> 20.0 x N |
|
Liver- clinical |
No change from baseline |
----- |
----- |
precoma |
hepatic coma |
|
Kidney, bladder |
| Creatinine |
WNL |
< 1.5 x N |
1.5 - 3.0 x N |
3.1 - 6.0 x N |
> 6.0 x N |
|
| Proteinuria |
No change |
1 (+) or < 0.3 g% or 3 g/L |
2 - 3 (+) or 0.3 - 1.0 g% or 3 - 10 g/L |
4 (+) or > 1.0 g% or > 10g/L |
nephrotic syndrome |
|
| Haematuria |
Negative |
microscopic only |
gross, no clots no Rx needed |
gross and clots bladder irrigation |
requires trans- fusion or
cystectomy |
|
Weight gain/ loss |
< 5.0 % |
5.0 - 9.9 % |
10.0 - 19.9 % |
20.0 % |
----- |
|
| Pulmonary |
none or no change |
asymptomatic, with abnormal- ity
in PFTs |
dyspnoea on significant
exertion |
dyspnoea at normal level of
activity |
dyspnoea at rest |
|
Cardiac |
Cardiac arrhythmias |
none |
asymptomatic, transient,
requiring no therapy |
recurrent or persistent, no therapy required |
requires treatment |
requires moni- toring; or hypo-
tension, or ventricular
tachycardia or fibrillation |
|
| Cardiac function |
none |
asymptomatic, decline of resting
ejection fraction by less than 20 %
of baseline value |
asymptomatic, decline of resting
ejection fraction by more than 20 %
of baseline value |
mild CHF, responsive to
therapy |
severe of refractory CHF |
|
| Cardiac ischaemia |
none |
non-specific T- wave flattening |
asymptomatic, ST and T wave changes
suggesting ischaemia |
angina without evidence of
infraction |
acute myocardial infarction |
|
Cardiac- pericardial |
none |
asymptomatic effusion, no
itervention required |
pericarditis (rub, chest pain, ECG
changes) |
symptomatic effusion; drainage
required |
tamponade; drainage
urgently required |
|
| Hypertension |
none or no change |
asymptomatic, transient increase
by greater than 20 mm Hg (D) or
to > 150 / 100 if previously WNL.
No treatment required. |
recurrent or persistent increase by
greater than 20 mm HG (D) or to > 150 /
100 if previously WNL. No treatment
required. |
requires therapy |
hypertensive crisis |
|
| Hypotension |
none or no change |
changes requiring no therapy (incl-
uding transient orthostatic hypo-
tension) |
requires fluid replacement or other
therapy but not hospitalisation |
requires therapy and hospitalisation;
resolves within 48 hours of stopping
the agent |
requires therapy and hospitalis-
ation for > 48 hrs after stopping
the agent |
|
Neurologic |
| Neuro: sensory |
none or no change |
mild paraesthesias; loss of deep
tendon reflexes |
mild or moderate objective sensory
loss moderate paraesthesias |
severe objective sensory loss or
paraesthesias that interfere with
function |
----- |
|
| Neuro: motor |
none or no change |
subjective weak- ness; no objective
findings |
mild objective weakness without
significant impair- ment of function |
objektive weak- ness with
impairment of function |
paralysis |
|
| Neuro: cortical |
none |
mild somnolence or agitation |
moderate somnolence or agitation |
severe somnolence, (>50 % waking
hours), agitation, confusion,
disorientation or hallucinations |
coma, seizures, toxic psychosis |
|
| Neuro: cerebellar |
none |
slight incoordination,
dysdiadochokinesia |
intention tremor, dysmetria, slurred
speech, nystagmus |
locomotor ataxia |
cerebellar necrosis |
|
| Neuro: mood |
no change |
mild anxiety or depression |
moderate anxiety or depression |
severe anxiety or depression |
suicidal ideation |
|
| Neuro: headache |
none |
mild |
moderate or severe but transient |
unrelenting and severe |
----- |
|
| Neuro: constipation |
none or no change |
mild |
moderate |
severe |
ileus > 96 hrs |
|
| Neuro: hearing |
none or no change |
asymptomatic, hearing loss on
audiometry only |
tinnitus |
hearing loss interfering with
function but correctable with
hearing aid |
deafness not correctable |
|
| Neuro: vision |
none or no change |
----- |
----- |
symptomatic subtotal loss of
vision |
blindness |
|
| Pain |
none |
mild |
moderate |
severe |
reg. narcotics |
|
| Skin |
none or no change |
scattered macular ot papular
eruption or erythema that is
asymptomatic |
scattered macular or papular eruption
or erythema with pruritus or other
associated symptoms |
generalised symptomatic macular,
papular or vesicular eruption |
exfoliative dermatitis or
ulcerating dermatitis |
|
| Alopecia |
no loss |
mild hair loss |
pronounced or total hair loss |
----- |
----- |
|
| Allergy |
none |
transient rash, drug fever < 38oC (100.4oF) |
urticaria, drug fever 38oC (100.4oF), mild bronchospasm |
serum sickness, bronchospasm
requiring parenteral medication |
anaphylaxis |
|
| Local |
none |
pain |
pain and swelling with inflammation
or phlebitis |
ulceration |
plastic surgery indicated |
|
| Fever of unknown origin |
none |
37.1 - 38.0o C
98.7o - 100.4o F |
38.1 - 40.0oC
100.5 - 104oF |
> 40.0oC >
104.0oF for less
than 24hrs |
> 40.0oC
(>104oF) for
more than 24 hrs or accompanied
by hypotension |
|
| Infection |
none |
mild |
moderate |
severe |
life-threatening |
|